Dual GIP/GLP-1 Agonist LY3298176 – Laboratory Grade (Tirzepatide)

Compound: Tirzepatide

Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20 diacid-gamma-Glu-(AEEA)2)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2

Format: Lyophilized Powder

Net Mass: 10mg / 20mg / 30mg per vial

Purity: ≥ 98% (HPLC)

CAS Number: 2023788-19-2

Molecular Formula: C225H348N48O68

Molecular Weight: 4813.45 g/mol

Specification: In Vitro Research Reagent

SKU: N/A Category:

Investigational dual agonist compound with activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Supplied as lyophilized preparation for metabolic pathway and insulin secretion research.

DISCLAIMER:
⚠️ FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is sold exclusively for in vitro research and laboratory analysis. It is not intended for human or animal consumption, administration, diagnostic use, or therapeutic application. This product has not been evaluated by any regulatory authority for safety or efficacy in humans. The buyer assumes full responsibility for proper handling, storage, and use in accordance with applicable research protocols. By purchasing, you certify that you are 18 years of age or older and qualified to handle research chemicals. This product is not a drug, medicine, or food supplement. Statements on this page have not been evaluated by the FDA, EMA, or Turkish Ministry of Health. This product is not intended to treat, cure, prevent, or diagnose any disease or medical condition. Use only as directed by qualified research personnel in appropriate laboratory settings.

Certificate of Analysis: Verified by independent laboratory testing done by Janoshik.

Quantity

10 x 10mg, 10 x 20mg, 10 x 30mg, 10 x 50mg, 10 x 60mg

Reviews

There are no reviews yet.

Be the first to review “Dual GIP/GLP-1 Agonist LY3298176 – Laboratory Grade (Tirzepatide)”

Your email address will not be published. Required fields are marked *

Contact Us